The American Society of Human Genetics (ASHG) is deeply concerned by the Executive Order (EO) issued last week titled “Improving Oversight of Federal Grantmaking.” While ASHG supports efforts to ensure transparency, accountability, and scientific rigor in federally funded research, we are particularly troubled that the EO’s directives risk introducing political considerations into the grantmaking process.... Read More
For Immediate Release: Thursday, March 21, 2024, 1:30 pm U.S. Eastern Time Media Contact: Kara Flynn, 202.257.8424, [email protected] ROCKVILLE, MD - The American Society of Human Genetics (ASHG) thanks Congress for sustaining its support for biomedical research in the FY 2024 conference agreement by funding the National Institutes of Health (NIH) at $47.1 billion. In a... Read More
November 8 saw a midterm election during which all members of the House of Representatives and one-third of the Senate were up for re-election. Democrats retained control of the Senate and Republicans ultimately won only a narrow majority in the House. This will usher in at least two years of divided government, and experts anticipate... Read More
The biomedical research system has historically been supported by two main pillars: fundamental research on the mechanisms of disease, largely funded by the National Institutes of Health (NIH), and the pharmaceutical industry, which creates products to treat these conditions. Recent advances in biomedical research and health sciences present an opportunity to change how we understand,... Read More
10 years ago, I was in my college dorm room writing my senior thesis and wondering what career could possibly combine my interest in genetics, health, communication, and translation of research. Today, I am sitting in my apartment in Washington, DC as an ASHG/NHGRI Genetics and Public Policy Fellow, working remotely at the intersection of... Read More